Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Immunology Letters|January 1, 2008
Immunosuppressive mechanisms in human tumors: why we still cannot cure cancerStefanie Gross, Peter Walden
Plos One|August 24, 2012
Hoxa11 and Hoxd11 regulate chondrocyte differentiation upstream of Runx2 and Shox2 in miceStefanie Gross, Yvonne Krause, Manuela Wuelling, et al.
Vaccine|February 10, 2009
Immunosuppressive mechanisms in cancer: consequences for the development of therapeutic vaccinesStefanie Gross, Astrid Geldmacher, Tumenjargal Sharav, et al.
Plos One|December 20, 2012
Ghrelin expression in the mouse pancreas defines a unique multipotent progenitor populationLuis Arnes, Jonathon T Hill, Stefanie Gross, et al.
Oncogene|January 16, 2002
Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 geneHendrik Bläker, Axel von Herbay, Roland Penzel, et al.
International Journal of Cancer|August 29, 2018
Senescence markers: Predictive for response to checkpoint inhibitorsAlvaro Moreira, Stefanie Gross, Michael Constantin Kirchberger, et al.
Biotechnology and Bioengineering|July 21, 2021
Engineering analysis of multienzyme cascade reactions for 3'-sialyllactose synthesisSabine Schelch, Manuel Eibinger, Stefanie Gross Belduma, et al.
Apoptosis : an International Journal on Programmed Cell Death|February 14, 2018
Hypertonicity primes malignant melanoma cells for apoptosisDiana Nicoleta Calance, Charlotte Steixner, Stefanie Gross, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 24, 2015
Nkx2.2 is expressed in a subset of enteroendocrine cells with expanded lineage potentialStefanie Gross, Dina Balderes, Jing Liu, et al.
Oncology Letters|November 4, 2017
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumorsOliver Bähr, Stefanie Gross, Patrick N Harter, et al.
Pageof 3